Rangering i aksjer
#17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aksjekurs
$5.84
Sist synkronisert: 2025-04-02
Handel Nevro Corp. (NVRO)
Pris NVRO pris med markedsverdi på B
Markedsverdi av Nevro Corp.(NVRO)
Markedsverdi: $224.09M
Per September 2026 har Nevro Corp. en markedsverdi på $224.09M. Dette gjør Nevro Corp. til det 17833rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Nevro Corp. fra 2014 til 2026
NVRO sammenlignet med topp 5 mest populære stocks
| Pris på NVRO |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.424T
|
+2,420,460.01%
|
|
|
|
|
$4.776T
|
+2,131,112.77%
|
|
|
|
|
$4.052T
|
+1,807,998.94%
|
|
|
|
|
$3.691T
|
+1,647,005.22%
|
|
|
|
|
$2.744T
|
+1,224,503.24%
|
